Is It A Rash Or Photosensitivity? FDA May Have To Distinguish Them In Simeprevir Label
Executive Summary
Antiviral Drugs Advisory Committee members debated whether both adverse reactions should be included in the simeprevir label’s “Warnings and Precautions” section and whether photosensitivity should automatically lead to stopping treatment.